trichlorfon has been researched along with Neurocysticercosis in 5 studies
Trichlorfon: An organochlorophosphate cholinesterase inhibitor that is used as an insecticide for the control of flies and roaches. It is also used in anthelmintic compositions for animals. (From Merck, 11th ed)
trichlorfon : A phosphonic ester that is dimethyl phosphonate in which the hydrogen atom attched to the phosphorous is substituted by a 2,2,2-trichloro-1-hydroxyethyl group.
Neurocysticercosis: Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four trials met the inclusion criteria, treating intraparenchymatous neurocysticercosis with either albendazole or praziquantel compared to placebo or no treatment." | 4.80 | Treating neurocysticercosis medically: a systematic review of randomized, controlled trials. ( Counsell, C; Garner, P; Gelband, H; Prasad, K; Salinas, R, 1999) |
| "Neurocysticercosis is an infection of the brain by the larval stage of the pork tapeworm." | 2.46 | Anthelmintics for people with neurocysticercosis. ( Abba, K; Ramaratnam, S; Ranganathan, LN, 2010) |
| "Neurocysticercosis is an infection of the brain by the larval stage of the pork tapeworm." | 2.46 | Anthelmintics for people with neurocysticercosis. ( Abba, K; Ramaratnam, S; Ranganathan, LN, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abba, K | 2 |
| Ramaratnam, S | 2 |
| Ranganathan, LN | 2 |
| Salinas, R | 3 |
| Prasad, K | 3 |
| Counsell, C | 1 |
| Gelband, H | 1 |
| Garner, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study[NCT04706819] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2021-01-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for trichlorfon and Neurocysticercosis
| Article | Year |
|---|---|
Anthelmintics for people with neurocysticercosis.
Topics: Adult; Albendazole; Anticestodal Agents; Brain Diseases; Child; Humans; Neurocysticercosis; Praziqua | 2010 |
Anthelmintics for people with neurocysticercosis.
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Anticestodal Agents; Brain Diseases; Child; Humans; Neu | 2010 |
WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain).
Topics: Albendazole; Anticestodal Agents; Brain Diseases; Humans; Neurocysticercosis; Praziquantel; Trichlor | 2007 |
Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.
Topics: Albendazole; Anthelmintics; Anticestodal Agents; Humans; Neurocysticercosis; Praziquantel; Randomize | 1999 |
Drugs for treating neurocysticercosis (tapeworm infection of the brain).
Topics: Albendazole; Anticestodal Agents; Brain Diseases; Humans; Neurocysticercosis; Praziquantel; Trichlor | 2000 |